Innate Pharma S.A. (FRA:IDDA)
Germany · Delayed Price · Currency is EUR 1.510
-0.020 (-1.31%)
At close: Jan 9, 2026
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €140.48 million as of January 9, 2026. Its market cap has decreased by -12.17% in one year.
Market Cap
140.48M
Enterprise Value
107.48M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.51
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 140.48M, an increase of 17,634.83%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 140.48M | -4.87% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |